发明名称 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation
摘要 <p>The present invention relates to the modulation of glucocorticoid metabolism. In particular, the invention relates to the modulation of the functional activity of the glucocorticoid receptor by 5± reduced metabolic breakdown products of glucocorticoids. The invention relates to the treatment of inflammatory conditions in a patient.</p>
申请公布号 EP1808176(B1) 申请公布日期 2013.10.23
申请号 EP20070004317 申请日期 2003.06.16
申请人 THE UNIVERSITY OF EDINBURGH 发明人 WALKER, BRAIN ROBERT;ANDREW, RUTH
分类号 A61K31/56;A61K45/00;A61K31/00;A61K31/405;A61K31/435;A61K31/473;A61K31/573;A61K31/59;A61P1/16;A61P3/02;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P17/00;A61P17/02;A61P17/10;A61P17/14;A61P25/00;A61P25/28;A61P29/00;A61P43/00 主分类号 A61K31/56
代理机构 代理人
主权项
地址